Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC728651 Inhibitors

LOC728651 inhibitors like staurosporine and Gö6983 are broad-spectrum kinase inhibitors that alter phosphorylation events within the cell. If LOC728651 is a phosphoprotein or interacts with kinase signaling pathways, these inhibitors could modulate its function. Compounds like LY294002 and PD98059 target upstream components of major signaling pathways and could have an effect if LOC728651 is part of these pathways.

Similarly, molecules like SP600125, SB203580, and U73122 inhibit various aspects of cellular signaling related to stress responses, inflammation, and receptor signaling. Their effects on these pathways could extend to LOC728651 if it is implicated in any of these cellular responses. Agents such as W-7 Hydrochloride and cyclosporin A that interfere with calcium signaling and calcineurin activity could impact LOC728651 if its function is calcium-dependent. Meanwhile, Bortezomib, a proteasome inhibitor, could affect the degradation of LOC728651, altering its cellular concentration. The inhibition methods range from modulation of kinase activity, interference with signaling cascades, alteration of cytoskeletal dynamics, to the inhibition of apoptosis and protein degradation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor that can disrupt phosphorylation-dependent signaling pathways possibly involving LOC728651.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$62.00
$90.00
$299.00
$475.00
$1015.00
$2099.00
69
(5)

An immunosuppressant that can inhibit calcineurin, potentially altering signaling pathways that LOC728651 may be a part of.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that can affect the AKT signaling pathway, potentially influencing processes regulated by LOC728651.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAP kinase inhibitor that can disrupt stress-related signaling pathways, possibly affecting LOC728651's role in such pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An ERK pathway inhibitor that could affect growth factor signaling, potentially impacting LOC728651's function if connected.

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$163.00
$300.00
$1642.00
18
(1)

A calmodulin antagonist that can interfere with calcium signaling, potentially affecting LOC728651 if it is calcium-dependent.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

Rac1 inhibitor that can disrupt actin cytoskeleton organization, potentially influencing LOC728651 if it is associated with cytoskeletal dynamics.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$74.00
256
(6)

A pan-caspase inhibitor that can block apoptosis, possibly affecting LOC728651 if it plays a role in apoptotic processes.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of c-Jun N-terminal kinase (JNK), potentially altering stress and inflammatory response pathways involving LOC728651.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

A broad spectrum protein kinase C inhibitor that could alter multiple signaling pathways, potentially including those involving LOC728651.